FindTrial
Sign In

Prospective study for the dissection of lymph node posterior to right recurrent laryngeal nerve for papillary thyroid carcinoma

Prospective study of the dissection for lymph node posterior to right recurrent laryngeal nerve for papillary thyroid carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019677
Enrollment
Unknown
Registered
2018-11-22
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary thyroid carcinoma

Interventions

Experience group:non LN-prRLN dissection
Control group:LN-prRLN dissection

Sponsors

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Phase I: (1) aged from 18 years old to 80 years old; (2) the primary treatment of patients with right or bilateral PTC; (3) patients will voluntarily enter the study after informed consent. Phase II: (1) aged from 18 years old to 80 years old; (2) the primary treatment of patients with right or bilateral PTC predicted to have no LN-prRLN metastasis by the "prediction model of LN-prRLN"; (3) patients will voluntarily enter the study after informed consent.

Exclusion criteria

Exclusion criteria: (1) patients refused to participate in the study; (2) non first operation patients; (3) other malignant tumor history; (4) distant metastasis; (5) history of neck trauma.

Design outcomes

Primary

MeasureTime frame
recurrence;Lymph node metastasis;—

Countries

China

Contacts

Public ContactLuo Dingcun

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine

ldc365@163.com+86 13732225858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026